Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Velasco-Durantez V, Cruz-Castellanos P, Hernandez R, Rodriguez-Gonzalez A, Fernandez Montes A, Gallego A, Manzano-Fernandez A, Sorribes E, Zafra M, Carmona-Bayonas A, Calderon C, Jimenez-Fonseca P. Prospective study of predictors for anxiety, depression, and somatization in a sample of 1807 cancer patients. Sci Rep. 2024 Feb 7;14(1):3188. doi: 10.1038/s41598-024-53212-y. PubMed PMID: 38326426; PubMed Central PMCID: PMC10850144.
AÑO: 2024; IF: 3.8
38326426
Guarnera L, D'Addona M, Bravo-Perez C, Visconte V. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. Int J Mol Sci. 2024 Aug 20;25(16):9023. doi: 10.3390/ijms25169023. PubMed PMID: 39201709; PubMed Central PMCID: PMC11354696.
AÑO: 2024; IF: 4.9
39201709
Hernandez-Sanchez A, Villaverde-Ramiro A, Arellano-Rodrigo E, Garrote M, Martin I, Mosquera-Orgueira A, Gomez-Casares MT, Ferrer-Marin F, Such E, Velez P, Ayala R, Angona A, de Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, de Villambrosia SG, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin A, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Perez-Encinas M, Bellosillo B, Alvarez-Larran A, Hernandez-Rivas JM, Hernandez-Boluda JC; Spanish MPN Group (GEMFIN). The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. Am J Hematol. 2024 Apr;99(4):755-758. doi: 10.1002/ajh.27203. Epub 2024 Jan 30. PubMed PMID: 38291566.
AÑO: 2024; IF: 10.1
38291566
Salas MQ, Cascos E, Lopez-Garcia A, Perez E, Baile-Gonzalez M, Martin Rodriguez C, Pascual Cascon MJ, Luque M, Esquirol A, Heras Fernando I, Pena-Munoz F, Oiartzabal Ormtegi I, Saez Marin AJ, Fernandez-Luis S, Dominguez-Garcia JJ, Villar Fernandez S, Fernandez de Sanmamed Giron M, Gonzalez Pinedo L, Garcia L, Gonzalez-Rodriguez AP, Torrado T, Filaferro S, Cedillo A, Orti G, Jurado Chacon M. Cardiac events after allo-HCT in patients with acute myeloid leukemia. Blood Adv. 2024 Nov 12;8(21):5497-5509. doi: 10.1182/bloodadvances.2024013535. PubMed PMID: 39178345; PubMed Central PMCID: PMC11538614.
AÑO: 2024; IF: 7.4
39178345
Santaliestra M, Garrote M, Noya MS, Perez-Encinas M, Senin A, Perez-Lopez R, Ferrer-Marin F, Carreno-Tarragona G, Caballero G, Magro E, Velez P, Cortes Vazquez MA, Moreto A, Angona A, Pastor-Galan I, Guerra JM, Garcia Hernandez C, Mata MI, Stuckey R, Gomez-Casares MT, Fox L, Cuevas B, Garcia-Gutierrez V, Triguero A, Arellano-Rodrigo E, Hernandez-Boluda JC, Alvarez-Larran A. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia. Leukemia. 2024 Dec;38(12):2636-2643. doi: 10.1038/s41375-024-02416-2. Epub 2024 Sep 27. PubMed PMID: 39333760.
AÑO: 2024; IF: 12.8
39333760
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL